OxySure Systems (OXYS) to Host Investor Day; Special Stockholder Meeting
To Take Place at Company Headquarters Tuesday September 15, 2015
Frisco, Texas, September 14, 2015 – OxySure Systems, Inc. (OTCQB: OXYS) (OxySure, or the Company), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its “oxygen from powder” technology and other medical solutions, today issued a reminder that the Company will conduct an Investor Day, from 10:00 a.m. to 11:30 p.m. CST on Tuesday, September 15, 2015. The event will be at the Company’s headquarters, located at 10880 John W. Elliott Drive, Suite 600, Frisco, Texas 75033, and will be hosted by Board members Tom Cox, Jerry Jones, and Julian Ross.
In addition, the Company will be conducting a Special Meeting of its stockholders on the same day, commencing at 12:00 noon CST pursuant to proxy statements that were mailed to stockholders on August 19, 2015. At the Special Meeting, stockholders are expected to vote on matters related to an uplisting of the Company to a national exchange such as Nasdaq and an amendment of the Company’s structure to facilitate significant future growth. Copies of the proxy statement can be found on the website of the Securities and Exchange Commission, located here:
http://www.sec.gov/Archives/edgar/data/1413797/000121390015006304/def14a0815_oxysuresyste.htm
A tour of the Company’s production plant and operations will be provided. In addition, Cliff Meidl, Two-Time Olympian, USA Olympic Team Flag Bearer and OxySure Spokesman, will provide a motivational presentation, as well as other survivors who will be available to share their lifesaving and life changing stories.
Availability for interested parties is extremely limited. Those interested in attending should contact Kathryn Jayne at 972-294-6551 or at kjayne@oxysure.com.
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from two dry, inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Forward-Looking Statements
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this release that are not historical facts, including, without limitation, statements that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development, may be deemed to be forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import also identify forward-looking statements. These statements are subject to risks and uncertainties. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. Except as may be required under applicable law, we assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of OxySure Systems, Inc. can be found in the filings of OxySure Systems, Inc. with the U.S. Securities and Exchange Commission.
OxySure Contacts:
Renmark Financial Communications, Inc.
Bettina Filippone: bfilippone@renmarkfinancial.com
Tel.: (416) 644-2020 or (514) 939-3989
Redchip Companies, Inc.
Jon Cunningham: jon@redchip.com
800-733-2447, ext. 107 | www.redchip.com/
Tags: